SmallCap
CompaniesStatistics

(주)알엔에이치바이오

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)알엔에이치바이오
Business Reg. No.8148702636
CEO홍준만
Address경기도 용인시
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products엑소좀
EstablishedContact
Phone031-895-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.131111-*******

Investment Metrics


Market Cap
-
Op. Margin
-1,114.1%
ROE
66.55%
Debt Ratio
-332.02%

Certification Status


Venture Certified

Cert. History
벤처투자유형2024-01-31 ~ 2027-01-30202401310100272024-01-31

Financial Statements


3-Year Financial Data

Revenue CAGR +75.8%

Item202420232022
Revenue

0.2B

0.3B

0.1B

Operating Profit

-2.3B

-1.2B

-0.3B

Net Profit

-2.6B

-1.2B

-0.3B

Total Assets

9.0B

6.7B

0.7B

Total Liabilities

12.8B

8.0B

0.7B

Total Equity

-3.9B

-1.3B

-0.1B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
210810K

27.2%

vs. 3-Year Avg.: 165710K
Operating Profit
-2B

214.2%

vs. 3-Year Avg.: -747410K
Op. Margin
-1114.1%

161.7%

vs. 3-Year Avg.: -425.7%
Debt Ratio
-332.0%

62.1%

vs. 3-Year Avg.: -875.9%
ROE
66.5%

73.7%

vs. 3-Year Avg.: 252.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
홍준만대표이사대표

Employment Status


Regular EmployeesContact
CEO홍준만

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "경기도 용인시",
  "ceo_name": "홍준만",
  "certificate": [
    {
      "cert_number": "20240131010027",
      "changes": "",
      "disclosure_date": "2024-01-31",
      "first_cert_date": "2024-01-31",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2024-01-31 ~ 2027-01-30"
    }
  ],
  "company_name": "(주)알엔에이치바이오",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 20000000,
      "cost_of_sales": 2500000,
      "current_assets": 66674000,
      "current_liabilities": 3110000,
      "gross_profit": 4318000,
      "net_income": -26436000,
      "net_income_bs": -26436000,
      "non_current_assets": 0,
      "non_current_liabilities": 70000000,
      "non_operating_expenses": 361000,
      "non_operating_income": 6000,
      "operating_profit": -26081000,
      "revenue": 6818000,
      "sga_expenses": 30399000,
      "total_assets": 66674000,
      "total_equity": -6436000,
      "total_liabilities": 73110000
    },
    "2023": {
      "capital_stock": 20000000,
      "cost_of_sales": 8365000,
      "current_assets": 157243000,
      "current_liabilities": 5561000,
      "gross_profit": 17958000,
      "net_income": -122735000,
      "net_income_bs": -122735000,
      "non_current_assets": 509147000,
      "non_current_liabilities": 790000000,
      "non_operating_expenses": 4982000,
      "non_operating_income": 5651000,
      "operating_profit": -123404000,
      "revenue": 26323000,
      "sga_expenses": 141362000,
      "total_assets": 666390000,
      "total_equity": -129171000,
      "total_liabilities": 795561000
    },
    "2024": {
      "capital_stock": 20000000,
      "cost_of_sales": 5839000,
      "current_assets": 341787000,
      "current_liabilities": 12089000,
      "gross_profit": 15243000,
      "net_income": -256976000,
      "net_income_bs": -256976000,
      "non_current_assets": 554155000,
      "non_current_liabilities": 1270000000,
      "non_operating_expenses": 29428000,
      "non_operating_income": 7320000,
      "operating_profit": -234868000,
      "revenue": 21082000,
      "sga_expenses": 250111000,
      "total_assets": 895942000,
      "total_equity": -386147000,
      "total_liabilities": 1282089000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2023-07-12"
    }
  ],
  "main_products": "엑소좀",
  "phone": "031-895-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected